Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Low-dose Single-wavelength Red Light in the Decrease of Myopia Incidence Rate in the Setting of School.

NCT04825769 is registered in ClinicalTrials.gov with Shanghai Eye Disease Prevention and Treatment Center as lead sponsor.

NCT NCT04825769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04825769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Low-dose Single-wavelength Red Light in the Decrease of Myopia Incidence Rate in the Setting of School.
Lead sponsor
Shanghai Eye Disease Prevention and Treatment Center
Phase
Not applicable
Overall status
Completed
Start date
March 25, 2021
Completion date
August 31, 2022
Enrollment
278 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia